A RANDOMIZED, OPEN-LABEL, PARALLEL, PROSPECTIVE STUDY COMPARING THE EFFECTIVENESS AND TOLERABILITY OF DULOXETINE, SERTRALINE, AND ESCITALOPRAM IN TREATING MAJOR DEPRESSIVE DISORDER. A-JMRHS 2026, 4 (01), 203-208. https://doi.org/10.65605/a-jmrhs.2026.v04.i01.pp203-208.